文献速递乳房整形与再造创面修复

脱细胞真皮基质用于即刻组织扩张器重建联合放疗的结局:一项回顾性队列研究

Outcomes of Acellular Dermal Matrix for Immediate Tissue Expander Reconstruction with Radiotherapy: A Retrospective Cohort Study.
PubMed 文献 · Aesthet Surg J · 2019-01-01

该回顾性队列研究纳入2004至2014年MD安德森癌症中心957例(1370侧)即刻组织扩张器乳房重建患者,分为ADM、ADM联合PMRT、非ADM、非ADM联合PMRT四组。ADM组总体并发症率39.0%高于非ADM组16.7%(P<0.001),但放疗组中ADM组取出率显著更低。作者认为使用ADM应谨慎,但在需PMRT的病例中可能有作用。

要点

  • ADM组总体并发症率39.0%高于非ADM组16.7%(P<0.001)。
  • 乳房切除皮瓣坏死是最常见并发症,其次为感染。
  • 放疗组中ADM组取出率显著低于非ADM放疗组。

核心结论

  • 使用ADM进行扩张器乳房重建应谨慎,因总体并发症率(包括感染和血清肿)较高。
  • 在需要PMRT的病例中ADM可能有作用,因种植失败总体发生率低于非ADM病例。

研究设计与样本

  • 回顾性队列研究,纳入2004至2014年MD安德森癌症中心接受即刻组织扩张器乳房重建的患者。
  • 共957例患者、1370侧重建,分为ADM组、ADM联合PMRT组、非ADM组、非ADM联合PMRT组(非ADM 683例、非ADM联合PMRT 113例、ADM 486例、ADM联合PMRT 88例)。

主要发现

  • ADM组总体并发症率为39.0%,非ADM组为16.7%(P<0.001)。
  • 两队列中乳房切除皮瓣坏死均为最常见并发症,其次为感染。
  • 在放疗组和非放疗组中,ADM使用均与感染和血清肿发生率显著升高相关。
  • 在放疗队列中,ADM组的取出发生率显著低于非ADM组。

临床怎么用

  • 作者认为使用ADM进行扩张器乳房重建应谨慎,因总体并发症率(包括感染和血清肿)较高。
  • 作者认为在需要PMRT的病例中ADM可能有作用,因种植失败总体发生率低于非ADM病例。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite increasing literature support for the use of acellular dermal matrix (ADM) in expander-based breast reconstruction, the effect of ADM on clinical outcomes in the presence of post-mastectomy radiation therapy (PMRT) has not been well described. OBJECTIVES: To analyze the impact ADM plays on clinical outcomes on immediate tissue expander (ITE) reconstruction undergoing PMRT. METHODS: We retrospectively reviewed patients who underwent ITE breast reconstruction from 2004 to 2014 at MD Anderson Cancer Center. Patients were categorized into four cohorts: ADM, ADM with PMRT, non-ADM, and non-ADM with PMRT. Outcomes and complications were compared among cohorts. RESULTS: Over 10 years, 957 patients underwent ITE reconstruction (683 non-ADM, 113 non-ADM with PMRT, 486 ADM, and 88 ADM with PMRT) with 1370 reconstructions. Overall complication rates for the ADM and non-ADM cohorts were 39.0% and 16.7%, respectively (P < 0.001). Within both cohorts, mastectomy skin flap necrosis (MSFN) was the most common complication, followed by infection. ADM use was associated with a significantly higher rate of infections and seromas in both radiated and non-radiated groups; however, when comparing radiated cohorts, the incidence of explantation was significantly lower with the use of ADM. CONCLUSIONS: The decision to use ADM for expander-based breast reconstruction should be performed with caution, given higher overall rates of complications, including infections and seromas. There may, however, be a role for ADM in cases requiring PMRT, as the overall incidence of implant failure is lower than non-ADM cases.

来源:Aesthet Surg J,查看原文。版权归原作者所有。

引用

  1. Craig ES, Clemens MW, Koshy JC, et al. Outcomes of Acellular Dermal Matrix for Immediate Tissue Expander Reconstruction with Radiotherapy: A Retrospective Cohort Study. Aesthet Surg J. 2019. PMID: 29800083. doi:10.1093/asj/sjy127

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。